Skip to main content

Table.1 Characteristics of the studies in meta-analysis for the diagnosis of PJI applying Calprotectin

From: Synovial calprotectin for the diagnosis of periprosthetic joint infection: a diagnostic meta-analysis

Study

Year

Country

Study design

Gender (M/F)

Mean age*

BMI*

Detection method

Cutoff values

Gold standard

Dariusz Grzelecki et al

2021

Poland

P

25/60

68.3 / 65.5

29.3/ 29.9

Immunoturbidimetric Calprotectin Immunoassay (GCal, Gentian, Moss, Norway)

1.5 mg/L

ICM (2018)

Jared Warren et al

2021

USA

P

57/66

65.4 / 66.9

32.0/ 34.2

Lyfstone Calprotectin Point of Care Test Kit (Lyfstone)

50 mg/L

MSIS (2013)

Alexander J Trotter et al

2020

TUK

R

37/32

NA

NA

The Lyfstone calprotectin test (Lyfstone AS, Tromsø, Norway)

14 mg/L

ICM (2018)

Marjan Wouthuyzen-Bakker et al

2017

Netherlan-ds

P

25/36

60/65

NA

The Rapid Calprotectin High Range Quantum Blue Assay (BÃœHLMANN laboratories AG)

50 mg/L

MSIS (2011)

Marjan Wouthuyzen-Bakker et al

2018

Netherlan-ds

P

NA

NA

NA

The Rapid Calprotectin High Range Quantum Blue Assay (BÃœHLMANN laboratories AG)

50 mg/L

MSIS (2011)

Paolo Salari et al

2019

Italy

P

36/40

NA

NA

Calprest NG (Eurospital, Trieste, Italy)

50 mg/L

ICM (2018)

Zeyu Zhang et al

2019

China

P

20/43

NA

NA

ELISA (Hycult Biotech, Uden, the Netherlands)

173 ug/ml

MSIS (2013)

  1. *The values were given as the number with Non-PJI / PJI, P prospective study, R retrospective study, NA not applicable